Catalyst Wire Dossier Catalyst Wire Dossier

TEV-53275

· Teva Branded Pharmaceutical Products R&D, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TEV-53275, covering 2023-06-08 to 2023-06-08. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test if TEV-53275 is Effective in Relieving Asthma [Phase 2]

See pricing